Science Fiction is now True in 2022
Global Cancer Technology is innovating the treatment of deadly diseases like glioblastoma – it’s not science fiction any more! Scintillating nanoparticles can theoretically be coated in GCT’s cancer inhibitor that is currently being tested in animal models, then be injected into the bloodstream and designed to bind to the tumor’s surface.
The Future of Cancer Treatment Looks Bright
Over the last few months, more than $30 billion has been invested in biotechnology companies to spur research and development, particularly in the area of cancer treatments. Companies like Global Cancer Technology are developing innovative treatments in an effort to one day halt the progression of deadly diseases like glioblastoma.
Why are Cancer Patients Skipping Their Treatments?
Cancer patients have been skipping their treatments since the pandemic began. In some cases, clinics have temporarily closed their facilities or halted their procedures due to the outbreak; in other cases, patients have been afraid of contracting the virus.
Imagion to develop nanocrystals for treating breast cancer
Early cancer detection specialist Imagion Biosystems Limited (ASX: IBX) has entered into a Joint…
Biotech Daily (newsletter) – Imagion, GCT work on nano-scintillator for breast cancer
Thursday August 12, 2021 Daily news on ASX-listed biotechnology companies * AS X FLAT, BIOTECH…
Imagion Biosystems (ASX:IBX) up on deal to develop breast cancer treatment
Shares of Imagion Biosystems (ASX:IBX) jumped as much as 9% to AU$0.085, their highest since…
Imagion Biosystems Enters Agreement to Develop Nanocrystals for Treating Breast Cancer
Imagion Biosystems is pleased to announce it has entered into a Joint Development Agreement…